Bioiberica and Apsen continue partnership, develop new joint health product for Brazilian market

Bioiberica has partnered with Apsen to develop a mobility product for the Brazilian market. The product, Motilex HA, combines two of Bioiberica’s leading joint health ingredients: b-2Cool native type 2 collagen, and Mobilee hyaluronic acid.

Bioiberica (Barcelona, Spain) has partnered with Apsen to develop a mobility product for the Brazilian market. The product, Motilex HA, combines two of Bioiberica’s leading joint health ingredients: b-2Cool native type 2 collagen, and Mobilee, a patented ingredient that synergistically combines a high concentration of hyaluronic acid with polysaccharides and collagen. A recent rabbit model of induced osteoarthritis found that the combination of these ingredients, along with chondroitin sulfate, glucosamine hydrochloride, had greater efficacy than placebo, and Mobilee with chondroitin sulfate, glucosamine hydrochloride. Of course, both interventions had significantly greater efficacy than placebo. Prior to Motilex HA, the two companies partnered to develop Motilex, which is a powdered food supplement containing b-2Cool.

“Following the successful development of Motilex, we recognised an opportunity in the market to leverage our combined technical and market expertise and respond to the growing trend for holistic mobility solutions,” said Jaume Reguant, healthcare director at Bioiberica, in a press release. “Rather than focusing on joints and muscles in isolation, we’ve worked closely with Apsen to expand its range and create a new product which uses a powerful combination of hyaluronic acid, polysaccharides, and collagen in the form of Mobilee, alongside native type II collagen to provide health-conscious consumers with an effective solution that supports overall mobility and enables them to achieve their health goals.”

“Brazil is a priority market for both Apsen and Bioiberica, where Motilex, containing b-2Cool, is currently the market leader,” adds Kleber Vargas, vice president of new business at Apsen. “The mobility market continues to evolve rapidly in the region and it’s for this reason that we choose to partner with organisations, like Bioiberica, which can support us in the development of cutting-edge solutions with market standout through the provision of high-quality, science-backed ingredients.”